...
首页> 外文期刊>Medical hypotheses >Combination of bupropion, paroxetine and quetiapine as adjuvant treatment for multiple myeloma.
【24h】

Combination of bupropion, paroxetine and quetiapine as adjuvant treatment for multiple myeloma.

机译:安非他酮,帕罗西汀和喹硫平联用作为多发性骨髓瘤的辅助治疗。

获取原文
获取原文并翻译 | 示例

摘要

Multiple myeloma is a severe plasma dyschrasia with no known treatment or cure, even bone marrow transplantation. Cytokines such as tumor necrosis factor-alpha (TNF) and interleukin-6 (Il-6) are thought to be important trophic factors for the malignant plasma cells. In turn, histamine and nitric oxide are positive regulatory factors for Il-6. Here we note that the safe, approved and commonly used psychiatric medicines bupropion (Wellbutrin), paroxetine (Paxil) and quetiapine (Seroquel) are respectively potent TNF, nitric oxide and histamine antagonists and thus might find some use in treatment of multiple myeloma.
机译:多发性骨髓瘤是一种严重的血浆难治性疾病,没有已知的治疗或治愈方法,甚至没有骨髓移植方法。细胞因子例如肿瘤坏死因子-α(TNF)和白介素-6(Il-6)被认为是恶性浆细胞的重要营养因子。反过来,组胺和一氧化氮是II-6的正调节因子。在这里,我们注意到安全,批准并常用的精神药物安非他酮(Wellbutrin),帕罗西汀(Paxil)和喹硫平(Seroquel)分别是有效的TNF,一氧化氮和组胺拮抗剂,因此可能在治疗多发性骨髓瘤中有一定用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号